X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2856492/0/en/CENTOGENE-Receives-Nasdaq-Non-Compliance-Notice.html
https://www.globenewswire.com/news-release/2024/03/19/2848395/0/en/CENTOGENE-Extends-Strategic-Partnership-With-Takeda-to-Continue-Providing-Access-to-Genetic-Testing-for-Patients-With-Lysosomal-Storage-Disorders.html
https://www.globenewswire.com//news-release/2024/02/28/2836759/0/en/CENTOGENE-Announces-Receipt-of-Nasdaq-Notice-of-Delisting-and-Intention-to-Request-a-Hearing.html
https://www.globenewswire.com//news-release/2024/02/28/2836749/0/en/CENTOGENE-Explores-Strategic-Alternatives.html
https://www.globenewswire.com//news-release/2024/01/25/2816524/0/en/CENTOGENE-and-the-Laboratory-of-Human-Genetics-of-Infectious-Diseases-at-Institut-Imagine-Announce-Rare-Disease-Research-Collaboration.html
https://www.globenewswire.com//news-release/2024/01/24/2815050/0/en/CENTOGENE-Receives-French-Research-Tax-Credit-Accreditation.html
https://www.globenewswire.com//news-release/2024/01/23/2813910/0/en/CENTOGENE-and-The-Michael-J-Fox-Foundation-Announce-Research-Project-to-Validate-Genetic-Risk-Factors-of-Parkinson-s-Disease-Using-Multiomics.html
https://www.globenewswire.com//news-release/2024/01/18/2811370/0/en/CENTOGENE-Announces-Preliminary-Full-Year-2023-Revenue.html
https://www.globenewswire.com//news-release/2023/12/19/2798385/0/en/CENTOGENE-Announces-Voting-Results-of-Extraordinary-General-Meeting.html
https://www.globenewswire.com//news-release/2023/12/13/2795390/0/en/CENTOGENE-s-Frontotemporal-Dementia-FTD-Genetic-Study-EFRONT-Reaches-Initial-Patient-Enrollment-Milestone.html
Market Place
Share 
